John is the Biotechnology Investment Director at Uniseed, Australia’s longest running venture fund, with investment capital provided by nine leading Australian universities, the national science agency CSIRO and leading Australian Superannuation Fund, UniSuper. He is responsible for identifying new investment opportunities from Uniseed partner research organisations and also covers Uniseed’s overall biotechnology and life sciences portfolio.
John brings 28 years of industry experience as a Biotechnology Manager with a focus on the strategic design and implementation of drug development programs. John’s previous roles have included Pharmaceutical Development Manager at BioDiem Ltd., managing the preclinical, clinical and regulatory aspects of BioDiem’s drug development programs, and Preclinical Development Manager at Amrad Corporation Ltd., where he was responsible for the management of preclinical drug development projects.
His experience extends from drug discovery to the clinical phase of drug development. He has acted as a Director on the Board of investee companies that have collectively raised more than AU$350 million. John has a PhD in Neuroscience and a Post Graduate Diploma in Drug Evaluation & Pharmaceutical Science, both from the University of Melbourne, and is a graduate of the Australian Institute of Company Directors.
